Key result
A standardized anesthetic and surgical clinical pathway for esophageal resection achieved in-hospital and 30-day mortality rates of 0.5% each, despite increasing patient comorbidity burden.
Why the study?
Does a standardized anesthetic and surgical clinical pathway improve outcomes in patients undergoing esophageal resection?
Observational
No
Does a standardized anesthetic and surgical clinical pathway improve outcomes in patients undergoing esophageal resection?
A standardized perioperative pathway for esophagectomy is associated with low mortality and decreased length of stay despite increasing patient complexity.
Answers are grounded in this paper and cite their sources.
May support standardized pathways for esophagectomy amid rising comorbidities; hypothesis-generating and leaves open need for randomized confirmation.
BACKGROUND AND OBJECTIVES: Esophageal cancer is a leading cause of cancer death worldwide, and esophageal resection is associated with extremely high perioperative morbidity and mortality. A perioperative clinical pathway for esophagectomy patients in which anesthetic care is both integral and standardized has not been described previously. METHODS: A continuously refined clinical pathway for perioperative care of the esophagectomy patient has been developed at the Virginia Mason Medical Center over the past 22 years. Ongoing data collection records patient demographics, comorbidities, tumor stage, and various outcomes including intensive care unit and hospital length of stay, surgical complications, and morbidity and mortality rates. RESULTS: Over time, patients presenting for surgical treatment of esophageal cancer have had significantly higher Charlson comorbidity scores and a higher incidence of diabetes mellitus, hypertension, liver disease, and history of deep vein thrombosis or pulmonary embolism. During the same period, intensive care unit and hospital length of stays have decreased, whereas most complication rates have remained stable despite more advanced tumor stage and increased use of neoadjuvant chemoradiotherapy. In-hospital and 30-day mortality rates are well below national averages at 0.5% each. CONCLUSIONS: We present a detailed anesthetic and surgical perioperative pathway for esophageal resection, along with evidence of improved or stable patient outcomes despite an increase in comorbidity burden and increasingly advanced tumor stage.
No takes yet. Share an insight, caveat, or question.
Porteous et al. (2015) conducted an observational in Esophageal cancer. Standardized anesthetic and surgical clinical pathway was evaluated on In-hospital and 30-day mortality rates. A standardized anesthetic and surgical clinical pathway for esophageal resection achieved in-hospital and 30-day mortality rates of 0.5% each, despite increasing patient comorbidity burden.
Synapse has enriched 10 related papers. Consider them for comparative context: